What is a stock summary page? Click here for an overview.
New Key Statistics Module, Z-Score and F-Score
NAS:CSTL Key Ratios
| Market Cap $ M | 612.96 |
| Enterprise Value $ M | 367.23 |
| P/E(ttm) | 34.31 |
| PE Ratio without NRI | 34.31 |
| Forward PE Ratio | -- |
| Price/Book | 1.33 |
| Price/Sales | 1.89 |
| Price/Free Cash Flow | 17.75 |
| Price/Owner Earnings | 50.43 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 332.00 |
| EPS (TTM) $ | 0.62 |
| Beneish M-Score | -2.59 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 16.59 |
| EV-to-EBITDA | 9.63 |
| PEG | -- |
| Shares Outstanding M | 28.84 |
| Net Margin (%) | 5.49 |
| Operating Margin % | 2.61 |
| Pre-tax Margin (%) | 6.49 |
| Quick Ratio | 7.13 |
| Current Ratio | 7.29 |
| ROA % (ttm) | 3.73 |
| ROE % (ttm) | 4.31 |
| ROIC % (ttm) | 3.47 |
| Dividend Yield % | -- |
| Altman Z-Score | 5.98 |
CSTL Number of Guru Trades
CSTL Volume of Guru Trades
Gurus Latest Trades with NAS:CSTL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CSTL is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Castle Biosciences Inc Insider Transactions
No Available Data
News about NAS:CSTL
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers